Lv78
5008 积分 2021-11-03 加入
Update on T-Cell Lymphoma Epidemiology
2个月前
已完结
Pattern and Prevalence of Liver Involvement in Pediatric Acute Lymphoblastic and Myeloid Leukemia at Diagnosis
4个月前
已完结
Ponatinib vs Imatinib in Frontline Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
5个月前
已完结
Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib
6个月前
已完结
Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib
6个月前
已关闭
CML-417: ASCEMBL Phase 3 Health-Related Quality of Life (HRQL) Comparison of Asciminib and Bosutinib for Patients with Chronic Myelogenous Leukemia in Chronic Phase (CML-CP), Previously Treated with 2 or More Tyrosine Kinase Inhibitors (TKI)
9个月前
已完结
Asciminib in Newly Diagnosed Chronic Myeloid Leukemia
1年前
已完结
Peripheral T‐cell lymphomas
1年前
已完结
Phase I dose escalation and expansion study of golidocitinib, a highly selective JAK1 inhibitor, in relapsed or refractory peripheral T-cell lymphomas
1年前
已完结
Golidocitinib favorable for relapsed/refractory T‐cell lymphoma
1年前
已完结
Synergistic toughening of bio-inspired molybdenum disulfide-chitosan lignocellulosic nacre with photocatalytic properties
3年前
已驳回
Wegener's Granulomatosis Presenting as Wallenberg Syndrome: A Case Report
3年前
已采纳
Indoleamine 2,3-Dioxygenase Mediates Survival of Chronic Lymphocytic Leukemia B Cells through Aryl Hydrocarbon Receptor By Inducing Mcl1
3年前
已采纳
皖公网安备34019202002308
